文献速递妇科产科

生命终末期大肠梗阻的结肠造口:姑息手术患者能获得什么?

A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery?
PubMed 文献 · Gynecol Oncol · 2024-06-29

本研究回顾性分析了2014年3月至2023年1月在本机构因恶性大肠梗阻行姑息性结肠造口的78例晚期妇科癌症患者,中位总生存期为4.5个月(95% CI:2.9-6.0),15.4%的患者在术后30天内死亡,26.9%在60天内死亡;生命最后30天内,62.7%的患者再次入院,53.0%就诊急诊科,18.5%入住重症监护室。

要点

  • 因恶性大肠梗阻行姑息性结肠造口的晚期妇科癌症患者中位总生存期仅4.5个月(95% CI:2.9-6.0)。
  • 26.9%的患者在术后60天内死亡,15.4%在术后30天内死亡。
  • 生命最后30天内,62.7%再次入院,53.0%就诊急诊科,18.5%入住重症监护室。

核心结论

  • 相当比例的患者在手术后60天内死亡,且许多患者在生命终末期有较高的医疗资源使用。

研究设计与样本

  • 回顾性分析2014年3月至2023年1月在本机构因恶性大肠梗阻行姑息性结肠造口的晚期妇科癌症患者,共纳入78例。

主要发现

  • 手术时中位年龄61岁(范围:34-83),大多数为复发性卵巢癌、输卵管癌或原发性腹膜癌(n=51,65.4%),其次为宫颈癌(n=16,20.5%)和子宫癌(n=10,12.8%)。
  • 中位Charlson合并症指数为3,术后中位住院时间为5天(范围:1-26)。
  • 所有患者的中位随访时间为4.5个月(范围:0.07-46.2),中位总生存期为4.5个月(95% CI:2.9-6.0),其中12例(15.4%)总生存期<30天,21例(26.9%)<60天。
  • 生命最后30天内,62.7%的患者再次入院,53.0%就诊急诊科,18.5%入住重症监护室。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Malignant large bowel obstruction (LBO) is a frequent complication affecting women with gynecologic cancers and is an indication for emergent surgery. However, the life expectancy and subsequent medical care utilization are unknown. We sought to estimate overall survival (OS) following colostomy and describe subsequent healthcare utilization among patients with advanced gynecologic malignancies. METHODS: We conducted a retrospective analysis of patients with advanced gynecologic cancers who underwent colostomy with palliative intent due to LBO at our institution between March 2014 and January 2023. Summary statistics were used to describe the clinical and demographic characteristics of the study population. OS was estimated using the Kaplan-Meier method, and we defined healthcare utilization at the end-of-life using criteria published by the National Quality Forum. RESULTS: A total of 78 patients were included. The median age at the time of surgery was 61 (range: 34-83), and most patients had recurrent ovarian, fallopian tube, or primary peritoneal cancer (n = 51, 65.4%), followed by cervical cancer (n = 16, 20.5%), and uterine cancer (n = 10, 12.8%). The median Charlson comorbidity index was 3 and median postoperative length of stay was five days (range: 1-26). The median follow-up for all patients was 4.5 months (range: 0.07-46.2), and the median OS was 4.5 months (95% CI: 2.9-6.0), including 12 patients (15.4%) with <30-day OS and 21 (26.9%) with <60-day OS. In the last 30 days of life, 62.7% of patients were re-admitted to the hospital, 53.0% were seen in the emergency department, and 18.5% were admitted to an intensive care unit. CONCLUSIONS: A significant proportion of patients died within 60 days of surgery, and many had high healthcare utilization at the end of life.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wilke RN, Iniesta MD, Fellman B, et al. A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery? Gynecol Oncol. 2024. PMID: 38945019. doi:10.1016/j.ygyno.2024.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。